Reporter March 5 2021

March 9, 2021

Markers for breast cancer progression

Vanderbilt researchers clarify how a microRNA associated with triple-negative breast cancer survival inhibits cancer progression, suggesting new treatment strategies.

By Sarah E. Glass
March 8, 2021

Temperature, newts and a skin-eating fungus

Salamanders are more sensitive to a skin-eating fungus at colder temperatures, pointing to locations of North America where pathogen invasion is most likely.

By Leigh MacMillan
March 5, 2021

VUMC mourns loss of radiology pioneer Payne

W. Faxon Payne, MD, who helped establish the outpatient radiology service at The Vanderbilt Clinic beginning in 1987 until his appointment as emeritus professor in 1995 and retirement in 2000, died Feb. 16. He was 95.

By VUMC News and Communications
March 4, 2021

Probiotic protection

A probiotic factor given early in life to mice prevented intestinal inflammation in adulthood, providing a rationale for probiotic intervention in individuals at high risk of developing inflammatory bowel disease.

By Anivarya Kumar
March 4, 2021

Monoclonal antibody “cocktail” blocks COVID-19 variants: study

A monoclonal antibody “cocktail” developed at Vanderbilt University Medical Center to neutralize the COVID-19 virus is effective against all known strains, or variants, of the virus, according to a report published today in the journal Nature Medicine.

By Bill Snyder
March 4, 2021

Targeting glucagon action in diabetes

Disrupting the action of glucagon — a pancreatic hormone that works to raise blood glucose — restores functional insulin-producing cells in mouse models of type 1 diabetes and may be a promising treatment strategy.

By Leigh MacMillan
March 4, 2021

Clinic helps prepare young HIV patients for adult care

Adolescents and young adults living with HIV in Middle Tennessee are being ushered into adult care through a special transition clinic that focuses on adult skill-building and individualized therapy and discussions.
By Nancy Humphrey
March 4, 2021

VHAN collaborations strengthened members during pandemic

When the COVID-19 pandemic hit in 2020, members of the Vanderbilt Health Affiliated Network (VHAN) — a clinically integrated network in Tennessee and surrounding states that now includes more than 6,100 clinicians, 70 hospitals, 13 health systems and hundreds of physician practices and clinics — were hit with challenges they might have never previ
By Jill Clendening
March 4, 2021

COVID-19 survey data added to All of Us platform

In December 2020, the federal government’s massive precision medicine research initiative, All of Us (AoU), made available to qualified researchers initial results from its ongoing COVID-19 Participant Experience (COPE) Survey, as well as physical activity and heart rate data collected from Fitbit devices worn by AoU participants.
By Paul Govern
March 4, 2021

Biostatistician DeMets set for next Discovery Lecture

David DeMets, PhD, known for his work on statistical methods to monitor interim clinical trial data for early evidence of benefit or harm, will deliver the next web-based Discovery Lecture.
By Leigh MacMillan
March 4, 2021

Chikungunya antibody identified at VUMC moves forward

Evotec, a drug company headquartered in Hamburg, Germany, has begun a phase 1 clinical trial of a monoclonal antibody against the chikungunya virus that was identified at Vanderbilt University Medical Center.
By Bill Snyder
March 3, 2021

VUMC launches new medical equipment company Carefluent Connect

After two years of planning and regulatory approvals, Vanderbilt University Medical Center is preparing to launch a durable medical equipment (DME) company, Carefluent Connect, LLC.
By Paul Govern
March 3, 2021

REDCap Day highlights new features, innovative use cases

Each year at VUMC, REDCap Day brings together local users from VUMC, Vanderbilt University and Meharry Medical College for a morning of brief presentations on innovative use cases and new and upcoming features.
By Paul Govern
1 2